CSI Market
Sign In | Register

Syros Pharmaceuticals Inc (SYRS) Annual Balance Sheets

Annual · GAAP · USD millions
Access SYRS quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Syros Pharmaceuticals Inc manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent139.53
Restricted Cash and Cash Equivalents, Current0.00
Marketable Securities, Current SH0.00
Cash & Short-term Investments139.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.45
Total Current Assets144.98
Equipment/Property/Plant Net7.30
Long-term investments2.12
Other Assets, Noncurrent3.00
Contract With Customer Asset Net Current-
Operating Lease Right Of Use Asset12.19
Finance Lease Right Of Use Asset-
Total Assets168.17
Liabilities
Accounts Payable, Current AC11.54
Long-term Debt, Current Maturities LO6.67
Other Liabilities, Current18.47
Deferred Revenue, Current DE0.00
Total Current Liabilities36.68
Long-term debt34.56
Total Long-term Debt34.56
Incentive from Lessor DE0.00
Other liabilities, Noncurrent0.00
Accrued Liabilities And Employee Related Liabilities Current16.15
Operating Lease Liability Current2.32
Operating Lease Liability Noncurrent18.53
Warrant Liability Noncurrent61.75
Contract With Customer Liability Noncurrent-
Total Liabilities71.24
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock739.44
Retained Earnings / Accumulated Deficit-722.81
Other Equity0.00
Common Stockholder's Equity16.66
Total Stockholder's Equity16.66
Liabilities & Stockholder's Equity168.17
4 historic quarters locked

Sign in to unlock the full Syros Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Syros Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-036808

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License